Literature DB >> 18773178

[Successful use of allogeneic stem cell transplantation for treatment-refractory mycosis fungoides].

N P Hoff1, A Groffik, R Mota, U Pippirs, U R Hengge, G Kobbe, B Homey, D Bruch-Gerharz.   

Abstract

Mycosis fungoides is the most common type of cutaneous T-cell lymphoma and characterized by a chronic progressive course spanning decades. The choice of treatment options should be tailored to the stage depending on the extent and aggressiveness of the disease and taking the individual situation of the patient into consideration. Long-term complete remissions can only be achieved in the early phase of the disease, while there is no therapy that results in a cure or long-term remission in advanced stages. In young patients with a treatment-refractory course of mycosis fungoides, allogeneic stem cell transplantation represents an important alternative option to manage the disease since complete clinical remission can be obtained even in advanced stages.

Entities:  

Mesh:

Year:  2008        PMID: 18773178     DOI: 10.1007/s00105-008-1635-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  6 in total

Review 1.  The pathogenesis of mycosis fungoides.

Authors:  Michael Girardi; Peter W Heald; Lynn D Wilson
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

Review 2.  Long-term remission after allogeneic hematopoietic stem cell transplantation for refractory cutaneous T-cell lymphoma.

Authors:  Joan Guitart; Scott C Wickless; Yu Oyama; Timothy M Kuzel; Steve T Rosen; Ann Traynor; Richard Burt
Journal:  Arch Dermatol       Date:  2002-10

Review 3.  Mycosis fungoides and Sézary syndrome.

Authors:  Sam T Hwang; John E Janik; Elaine S Jaffe; Wyndham H Wilson
Journal:  Lancet       Date:  2008-03-15       Impact factor: 79.321

Review 4.  Older and new formulations of cladribine. Pharmacology and clinical efficacy in hematological malignancies.

Authors:  Tadeusz Robak; Anna Korycka; Ewa Robak
Journal:  Recent Pat Anticancer Drug Discov       Date:  2006-01       Impact factor: 4.169

Review 5.  Stem cell transplantation in advanced cutaneous T-cell lymphoma.

Authors:  Camille E Introcaso; Brian Leber; Kathleen Greene; Ravi Ubriani; Alain H Rook; Ellen J Kim
Journal:  J Am Acad Dermatol       Date:  2008-02-06       Impact factor: 11.527

6.  Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation.

Authors:  R J Jones; R F Ambinder; S Piantadosi; G W Santos
Journal:  Blood       Date:  1991-02-01       Impact factor: 22.113

  6 in total
  1 in total

Review 1.  Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma.

Authors:  Max Schlaak; Juliane Pickenhain; Sebastian Theurich; Nicole Skoetz; Michael von Bergwelt-Baildon; Peter Kurschat
Journal:  Cochrane Database Syst Rev       Date:  2013-08-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.